Login / Signup

Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease.

Johan BurischHe ZhangCasey Kar-Chan ChoongDavid NelsonApril NaegeliTheresa GibbleIris GoetzAlexander Egeberg
Published in: Therapeutic advances in gastroenterology (2021)
Administrative claims data can be useful for identifying patients exhibiting (F-calprotectin defined) flare-ups of their IBD. Clinically relevant events captured in the Danish national patient registry are associated with increased levels of calprotectin and hence increased disease activity, and can be used as valid outcomes in future studies.
Keyphrases